COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS
Position in PTGX — Protagonist Therapeutics, Inc
CIK 1083190
HARRISBURG, PA
Position in PTGX
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$1,757,184
+$225,512 QoQ
Shares Held
14,335
-1.4% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#150
of 341 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS holds $101,328,920 across 32 Biotechnology names. PTGX ranks #17 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
56,059 | $27,846,187 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
22,070 | $13,761,527 | |
| 3 | MRNA |
Moderna, Inc.
|
77,999 | $5,462,269 | |
| 4 | TECH |
BIO-TECHNE Corp
|
67,082 | $4,739,343 | |
| 5 | INCY |
Incyte Corp
|
37,066 | $4,201,801 | |
| 6 | 127,280 | $4,000,410 | |||
| 7 | ROIV |
Roivant Sciences Ltd.
|
107,945 | $3,820,173 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
15,021 | $3,619,610 |
All Filings in PTGX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,757,184 | 14,335 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $1,531,672 | 14,532 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $1,270,622 | 14,548 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $989,341 | 14,893 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $879,511 | 15,913 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $689,710 | 14,262 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $491,107 | 12,723 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $566,595 | 12,591 | Shares | Sole | 2024-11-07 | |
| No filing history on record for this holder in this stock. | ||||||